• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Genetic Predictors of the Development of Complications after Coronary Stenting.冠状动脉支架置入术后并发症发生的遗传预测因素
J Pers Med. 2022 Dec 22;13(1):14. doi: 10.3390/jpm13010014.
2
A Meta-Analysis on the Association Between Polymorphisms (rs3861950 T > C and rs1234313 A > G) and Susceptibility to Coronary Artery Disease.多态性（rs3861950 T>C和rs1234313 A>G）与冠状动脉疾病易感性之间关联的荟萃分析。
Front Physiol. 2020 Nov 26;11:539288. doi: 10.3389/fphys.2020.539288. eCollection 2020.
3
The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease.9号染色体p21区域CDKN2B-AS1基因变异与脂质代谢的关联：一种冠状动脉疾病的诊断前生物标志物。
Anatol J Cardiol. 2019 Jan;21(1):31-38. doi: 10.14744/AnatolJCardiol.2018.90907.
4
CLINICAL AND GENETIC FACTORS OF CARDIOVASCULAR EVENTS DEVELOPMENT AFTER PERCUTANEOUS CORONARY INTERVENTION.经皮冠状动脉介入治疗后心血管事件发展的临床和遗传因素。
Georgian Med News. 2021 Mar(312):52-56.
5
Case-control study on the association between the GATA2 gene and premature myocardial infarction in the Iranian population.GATA2 基因与伊朗人群早发性心肌梗死关联性的病例对照研究。
Herz. 2021 Feb;46(1):71-75. doi: 10.1007/s00059-019-04841-x. Epub 2019 Aug 29.
6
rs1234313 and rs45454293 are risk factors of cerebral arterial thrombosis, large artery atherosclerosis, and carotid plaque in the Han Chinese population: a case-control study.rs1234313 和 rs45454293 是汉族人群脑动脉血栓形成、大动脉粥样硬化和颈动脉斑块的危险因素：一项病例对照研究。
BMC Neurol. 2019 Feb 23;19(1):31. doi: 10.1186/s12883-019-1259-9.
7
Association of TNFSF4 polymorphisms with susceptibility to primary Sjögren's syndrome and primary biliary cirrhosis in a Chinese Han population.TNFSF4 多态性与中国汉族人群原发性干燥综合征和原发性胆汁性肝硬化易感性的关联。
Clin Exp Rheumatol. 2013 Jul-Aug;31(4):546-51. Epub 2013 Apr 22.
8
[Role of markers of inflammation and endothelial dysfunction in the prognosis of the development of cardiovascular complications in patients with coronary artery disease and metabolic syndrome after coronary stenting].[炎症和内皮功能障碍标志物在冠心病合并代谢综合征患者冠状动脉支架置入术后心血管并发症发生预后中的作用]
Kardiologiia. 2020 Sep 17;60(8):98-105. doi: 10.18087/cardio.2020.8.n966.
9
[Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].[心肌梗死中的遗传因素——β受体阻滞剂候选基因与全基因组研究结果]
Herz. 2002 Nov;27(7):649-61. doi: 10.1007/s00059-002-2432-1.
10
Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population.ITGAM、TNFSF4、TNFAIP3和STAT4基因多态性与北印度人群系统性红斑狼疮风险的关联
Lupus. 2018 Oct;27(12):1973-1979. doi: 10.1177/0961203318786432. Epub 2018 Jul 24.

本文引用的文献

1
The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population.载脂蛋白 CETP 基因常见 SNPs 及单倍型与拉脱维亚人群 HDL 胆固醇水平的关联。
PLoS One. 2013 May 13;8(5):e64191. doi: 10.1371/journal.pone.0064191. Print 2013.
2
Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population.美国成年人群中脂质相关基因变异与血脂关联的种族/族裔差异。
Circ Cardiovasc Genet. 2011 Oct;4(5):523-33. doi: 10.1161/CIRCGENETICS.111.959577. Epub 2011 Aug 10.
3
An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study.对早发冠心病同胞兄弟中炎症基因多态性的评估：GRACE-IMMUNE 研究。
BMC Med. 2010 Jan 13;8:5. doi: 10.1186/1741-7015-8-5.
4
The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts.MORGAM前瞻性队列中新发现的基因座对冠心病、中风及总死亡率的影响
Genet Epidemiol. 2009 Apr;33(3):237-46. doi: 10.1002/gepi.20374.
5
A simple salting out procedure for extracting DNA from human nucleated cells.一种从人有核细胞中提取DNA的简单盐析方法。
Nucleic Acids Res. 1988 Feb 11;16(3):1215. doi: 10.1093/nar/16.3.1215.

冠状动脉支架置入术后并发症发生的遗传预测因素

Genetic Predictors of the Development of Complications after Coronary Stenting.

作者信息

Taizhanova Dana, Kalimbetova Akerke, Bodaubay Roza, Toleuova Aliya, Toiynbekova Rakhima, Beysenbekova Zhazira, Visternichan Olga, Tauesheva Zauresh, Kadyrova Irina, Babenko Dmitriy, Akhmaltdinova Lyudmila, Kolesnichenko Svetlana, Kolesnikova Yevgeniya, Avdienko Olga V, Akilzhanova Ainur, Gerotziafas Grigorios T

机构信息

Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.

Shared Resource Laboratory, Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.

出版信息

J Pers Med. 2022 Dec 22;13(1):14. doi: 10.3390/jpm13010014.

DOI:10.3390/jpm13010014
PMID:36675675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863814/
Abstract

Due to the fact that there are scientific discussions about the significance of gene polymorphisms in the risk of developing cardiovascular complications after a percutaneous coronary intervention, it is of interest to evaluate the genetic predictors of the development of cardiovascular events. This study is a molecular genetic study. Association with the genes of biomarkers for inflammation and immune response increases the risk of cardiovascular events: rs1234313 (TNFSF4): (A/G, OR-4.57 (2.35-8.87), ≤ 0.0001), (A/G-A/A, OR-3.14 (1.75-5.63), ≤ 0.0001), and (A/G, OR = 4.01 (2.19-7.36), ≤ 0.0001); rs3184504 (SH2D3); ATXN2: (C/T, OR-2.53 (1.28-5.01), T/T, OR-2.99 (1.13-7.92), = 0.017)), (C/T-T/T, OR-2.61 (1.35-5.07), = 0.000), and (OR-1.89 (1.15-3.09), = 0.009)). According to the lipid metabolism biomarker genes, rs2943634: (A/C OR-2.57 (1.18-5.62), = 0.013); according to the endothelial biomarker genes, rs2713604: (DNAJB8-AS1; GATA2): (C/T, OR-4.27 (2.35-7.76), ≤ 0.0001), (C/T-C/C, OR-4.13 (2.31-7.40), ≤ 0.0001), (OR-4.05 (2.24-7.30), ≤ 0.0001), and (C/T, OR-3.46 (1.99-6.00), ≤ 0.0001). The regression analysis found that in the presence of the rs2943634 gene polymorphism, the risk of late cardiovascular events increases by 4.007 times with 95% CI (1.502:10.692), = 0.006. The genes of biomarkers for the risk of cardiovascular events are rs1234313(TNFSF4), rs3184504 (SH2D3; ATXN2), rs2943634, and rs2713604 (DNAJB8-AS1; GATA2). The only predictor of the development of new cardiovascular events was rs2943634, which belongs to the group of lipid metabolism biomarkers.

摘要

由于存在关于基因多态性在经皮冠状动脉介入治疗后发生心血管并发症风险中的意义的科学讨论，因此评估心血管事件发生的遗传预测指标具有重要意义。本研究是一项分子遗传学研究。与炎症和免疫反应生物标志物基因的关联会增加心血管事件的风险：rs1234313（TNFSF4）：（A/G，比值比-4.57（2.35 - 8.87），P≤0.0001），（A/G - A/A，比值比-3.14（1.75 - 5.63），P≤0.0001），以及（A/G，比值比 = 4.01（2.19 - 7.36），P≤0.0001）；rs3184504（SH2D3）；ATXN2：（C/T，比值比-2.53（1.28 - 5.01），T/T，比值比-2.99（1.13 - 7.92），P = 0.017），（C/T - T/T，比值比-2.61（1.35 - 5.07），P = 0.000），以及（比值比-1.89（1.15 - 3.09），P = 0.009）。根据脂质代谢生物标志物基因，rs2943634：（A/C比值比-2.57（1.18 - 5.62），P = 0.013）；根据内皮生物标志物基因，rs2713604：（DNAJB8 - AS1；GATA2）：（C/T，比值比-4.27（2.35 - 7.76），P≤0.0001），（C/T - C/C，比值比-4.13（2.31 - 7.40），P≤0.0001），（比值比-4.05（2.24 - 7.30），P≤0.0001），以及（C/T，比值比-3.46（1.99 - 6.00），P≤0.0001）。回归分析发现，存在rs2943634基因多态性时，晚期心血管事件的风险增加4.007倍，95%置信区间为（1.502:10.692），P = 0.006。心血管事件风险生物标志物基因包括rs1234313（TNFSF4）、rs